Evotec SE (NASDAQ:EVO – Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 115,762 shares were traded during mid-day trading, a decline of 14% from the previous session’s volume of 134,963 shares.The stock last traded at $3.52 and had previously closed at $3.61.
Evotec Stock Performance
The business has a 50 day simple moving average of $4.14 and a 200 day simple moving average of $4.09. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.99 and a current ratio of 2.09.
Institutional Investors Weigh In On Evotec
Several institutional investors have recently modified their holdings of the company. BNP Paribas Financial Markets acquired a new stake in shares of Evotec in the 4th quarter valued at about $27,000. CSS LLC IL acquired a new stake in shares of Evotec in the fourth quarter valued at approximately $50,000. Bank of America Corp DE grew its position in shares of Evotec by 262.5% during the fourth quarter. Bank of America Corp DE now owns 12,828 shares of the company’s stock worth $53,000 after acquiring an additional 9,289 shares during the last quarter. Lighthouse Investment Partners LLC acquired a new position in shares of Evotec in the 4th quarter valued at $166,000. Finally, DCF Advisers LLC raised its position in Evotec by 5.9% in the 4th quarter. DCF Advisers LLC now owns 229,871 shares of the company’s stock valued at $956,000 after purchasing an additional 12,816 shares during the last quarter. 5.81% of the stock is owned by hedge funds and other institutional investors.
Evotec Company Profile
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women’s health.
See Also
- Five stocks we like better than Evotec
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Top Stocks Investing in 5G Technology
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Technology Stocks Explained: Here’s What to Know About Tech
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
